Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Corporate Profile

Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 230,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units - Research, Applied and SAFC Commercial - Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 37 countries, has more than 9,000 employees worldwide and had sales of $2.7 billion in 2013. For more information about Sigma-Aldrich, visit its website at www.sigma-aldrich.com.

Recent Releases

Aug 14, 2014
Cerilliant Introduces New Certified Spiking Solutions® of 2C Amine Internal Standards

Jul 29, 2014
Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives

Jul 24, 2014
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.

View all releases »


 

© 2014 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher